Skip to main content
. 2022 Dec 7;50(4):1228–1239. doi: 10.1007/s00259-022-06068-1

Fig. 5.

Fig. 5

Uptake of [99mTc]Tc-HFAPi in different lesions. T/B ratio (blue bar) and SUVmax (red bar) are shown in primary malignancies (a) and metastatic lesions (b). c The comparison of [99mTc]Tc-HFAPi uptake between benign and malignant lesions. Data represent median ± interquartile range. ***, P < 0.001